PI3K targeting in breast cancer: the end of the beginning?

Bachelot Thomas; Campone Mario; Tredan Olivier

首页> 外文期刊>The lancet oncology >PI3K targeting in breast cancer: the end of the beginning?

【24h】

PI3K targeting in breast cancer: the end of the beginning?

机译：PI3K靶向乳腺癌的开始？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2016年第6期|共2页
作者
Bachelot Thomas; Campone Mario; Tredan Olivier;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Molecular pathways: PI3K pathway targets in triple-negative breast cancers [J] . GordonV., BanerjiS. Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第14期

机译：分子途径：PI3K途径靶向三阴性乳腺癌
2. Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression [J] . Dongya Yuan, Yuejun Liu, Baosan Han, Biology Open . 2017,第9期

机译：靶向长非编码RNA DANCR抑制三阴性乳腺癌进展靶向长非编码RNA DANCR抑制三阴性乳腺癌进展靶向长非编码RNA DANCR抑制三阴性乳腺癌进展
3. Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer [J] . Neil A. O’Brien, Martina S. J. McDermott, Dylan Conklin, Breast Cancer Research . 2020,第1期

机译：靶向激活的PI3K / MTOR信号传导克服了在激素受体阳性乳腺癌的临床前模型中获得了基于CDK4 / 6的疗法的获得性
4. Micellar Nanomedicine for PI3K Inhibition in Breast Cancer [C] . E. Blanco, T. Sangai, F. Meric-Bernstam, Annual meeting exposition of the Controlled Release Society . 2010

机译：胶束纳米药物在乳腺癌中抑制PI3K的作用
5. Targeting the MEK5, MEK1/2, and/or Pi3k Pathways Reverses Epithelial to Mesenchymal Transition and Enhances Chemotherapeutic Sensitivity in Breast and Brain Cancers with a Mesenchymal Phenotype [D] . Bhatt, Akshita B. 2021

机译：靶向MEK5，MEK1 / 2和/或PI3K途径将上皮细胞转型的上皮性反转，并通过间充质表型提高乳腺癌和脑癌中的化疗敏感性
6. Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers [O] . Aadhya Tiwari, Mari Iida, Corinna Kosnopfel, 2020

机译：通过同时靶向PI3K和MAPK在三重阴性乳腺癌中阻断Y盒结合蛋白-1
7. PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening [O] . Jangsoon Lee, Huey Liu, Troy Pearson, 2021

机译：PI3K和MAPK途径作为与Pan-Shion的不可逆抑制剂内替替尼在Her2阳性乳腺癌和TNBC的靶向组合的靶标
8. Approaching Resistance to Targeted Inhibition of PI3K in Breast Cancer [R] . Ilic, N. 2011

机译：接近对乳腺癌中靶向抑制pI3K的抗性

PI3K targeting in breast cancer: the end of the beginning?

著录项

相似文献

相关主题

期刊订阅